Squarepoint Ops LLC Has $5.43 Million Stake in Doximity, Inc. (NASDAQ:DOCS)

Squarepoint Ops LLC cut its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 0.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 194,037 shares of the company’s stock after selling 1,779 shares during the quarter. Squarepoint Ops LLC’s holdings in Doximity were worth $5,427,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Blair William & Co. IL raised its stake in Doximity by 31.7% during the first quarter. Blair William & Co. IL now owns 90,600 shares of the company’s stock worth $2,438,000 after buying an additional 21,787 shares during the last quarter. Pinebridge Investments L.P. bought a new position in shares of Doximity in the 4th quarter worth about $2,845,000. Federated Hermes Inc. lifted its stake in shares of Doximity by 1,824.5% in the 2nd quarter. Federated Hermes Inc. now owns 279,634 shares of the company’s stock valued at $7,821,000 after purchasing an additional 265,104 shares during the period. Acadian Asset Management LLC boosted its position in shares of Doximity by 128.7% during the 1st quarter. Acadian Asset Management LLC now owns 96,442 shares of the company’s stock valued at $2,590,000 after purchasing an additional 54,281 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its stake in Doximity by 15,714.3% during the second quarter. Nisa Investment Advisors LLC now owns 11,070 shares of the company’s stock worth $310,000 after purchasing an additional 11,000 shares during the period. Institutional investors own 87.19% of the company’s stock.

Doximity Trading Up 1.5 %

Shares of Doximity stock opened at $43.56 on Tuesday. The company has a market capitalization of $8.08 billion, a P/E ratio of 60.50, a price-to-earnings-growth ratio of 5.80 and a beta of 1.27. The stock has a fifty day simple moving average of $35.11 and a 200 day simple moving average of $29.70. Doximity, Inc. has a 12-month low of $19.89 and a 12-month high of $43.99.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The firm had revenue of $126.68 million during the quarter, compared to analyst estimates of $119.88 million. On average, analysts predict that Doximity, Inc. will post 0.8 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have issued reports on DOCS shares. Bank of America boosted their price target on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research note on Friday, August 9th. Canaccord Genuity Group increased their target price on shares of Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Barclays raised their price target on shares of Doximity from $31.00 to $35.00 and gave the stock an “equal weight” rating in a report on Friday, August 9th. Wells Fargo & Company lowered shares of Doximity from an “equal weight” rating to an “underweight” rating and dropped their price objective for the company from $27.00 to $19.00 in a report on Thursday, July 18th. Finally, Needham & Company LLC upgraded Doximity from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a research note on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Doximity currently has a consensus rating of “Hold” and a consensus target price of $32.42.

Insider Buying and Selling at Doximity

In other news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now owns 309,627 shares in the company, valued at approximately $10,836,945. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of the firm’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $25.54, for a total transaction of $25,820.94. Following the completion of the sale, the director now owns 11,258 shares in the company, valued at $287,529.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the completion of the sale, the chief financial officer now directly owns 309,627 shares in the company, valued at approximately $10,836,945. The disclosure for this sale can be found here. In the last 90 days, insiders sold 35,451 shares of company stock worth $1,201,018. Insiders own 39.40% of the company’s stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.